100 related articles for article (PubMed ID: 12107769)
1. Evaluation of the histoculture drug response assay as a sensitivity test for anticancer agents.
Suda S; Akiyama S; Sekiguchi H; Kasai Y; Ito K; Nakao A
Surg Today; 2002; 32(6):477-81. PubMed ID: 12107769
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
3. [Chemosensitivity test for gastric carcinoma].
Kubota T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):495-500. PubMed ID: 9063490
[TBL] [Abstract][Full Text] [Related]
4. Potential of the histoculture drug-response assay to contribute to cancer patient survival.
Kubota T; Sasano N; Abe O; Nakao I; Kawamura E; Saito T; Endo M; Kimura K; Demura H; Sasano H
Clin Cancer Res; 1995 Dec; 1(12):1537-43. PubMed ID: 9815954
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
6. A feasibility study of chemosensitivity assay by adhesive tumor cell culture system using biopsy specimens for gastric cancer.
Suzuki T; Ochiai T; Nakajima K; Matsubara H; Arima M; Hori S; Hayashi H; Shimada H; Takeda A; Yanagawa T; Sen K
J Surg Oncol; 2000 Jun; 74(2):141-7. PubMed ID: 10914825
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of chemotherapy based on an in vitro chemosensitivity test in urothelial cancer patients.
Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Anticancer Res; 2001; 21(6A):4061-6. PubMed ID: 11911292
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of chemosenstivity tests in osteosarcoma using a histoculture drug response assay.
Lee SY; Jeon DG; Cho WH; Song WS; Kim MB; Park JH
Anticancer Res; 2006; 26(4B):2929-32. PubMed ID: 16886615
[TBL] [Abstract][Full Text] [Related]
9. Histoculture drug response assay predicts the postoperative prognosis of patients with esophageal cancer.
Fujita Y; Hiramatsu M; Kawai M; Nishimura H; Miyamoto A; Tanigawa N
Oncol Rep; 2009 Feb; 21(2):499-505. PubMed ID: 19148528
[TBL] [Abstract][Full Text] [Related]
10. [The experiment and clinical evaluation of chemosensitivity test for esophageal and gastric cancer by ATP assay using endoscopic biopsy].
Kawano K
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):232-40. PubMed ID: 1513305
[TBL] [Abstract][Full Text] [Related]
11. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
[TBL] [Abstract][Full Text] [Related]
12. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
[TBL] [Abstract][Full Text] [Related]
13. Resistance to anticancer drugs of well differentiated gastric adenocarcinoma with venous invasion.
Sakaguchi Y; Anai H; Kohnoe S; Emi Y; Kusumoto T; Maehara Y; Sugimachi K
Eur J Surg Oncol; 1992 Apr; 18(2):142-5. PubMed ID: 1582507
[TBL] [Abstract][Full Text] [Related]
14. Independence of cytotoxic drug sensitivity profiles and receptor subtype of invasive ductal breast carcinoma demonstrated by the histoculture drug response assay (HDRA).
Kim KY; Chung BW; Yang I; Kim MB; Hoffman RM
Anticancer Res; 2014 Dec; 34(12):7197-201. PubMed ID: 25503149
[TBL] [Abstract][Full Text] [Related]
15. A fractal dimension analysis: a new method for evaluating the response of anticancer therapy.
Omori H; Nio Y; Yano S; Itakura M; Koike M; Toga T; Matsuura S
Anticancer Res; 2002; 22(4):2347-54. PubMed ID: 12174925
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
17. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
[TBL] [Abstract][Full Text] [Related]
18. Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer.
Meng H; Tanigawa N; Hao CY; Dai DJ; Lu CD; Ji JF
Hepatogastroenterology; 2007; 54(79):1934-40. PubMed ID: 18251132
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
20. [Dose response curve of paclitaxel measured by histoculture drug response assay].
Yoshimasu T; Oura S; Hirai I; Kokawa Y; Okamura Y; Furukawa T
Gan To Kagaku Ryoho; 2005 Apr; 32(4):497-500. PubMed ID: 15853216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
